| Home | E-Submission | Sitemap | Editorial Office
top_img
      
REVIEW
Acute kidney injury in liver cirrhosis: new definition and application
The traditional diagnostic criteria of renal dysfunction in cirrhosis are a 50% increase in serum creatinine (SCr) with a final value above 1.5 mg/dL. This means that patients with milder degrees of renal dysfunction are not being diagnosed, and therefore not offered timely trea...
REVIEW
Management of direct antiviral agent failures
The current standard of care for patients with chronic hepatitis C virus (HCV) infection is a combination of direct-acting antiviral agents (DAAs). Most HCV patients treated with these drugs achieve viral elimination, but 1% to 15% fail to attain this objective. Treatment failur...
ORIGINAL ARTICLE
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Background/Aims: It remains to be determined whether switching from adefovir (ADV) to tenofovir (TDF) provides better virological outcomes in patients exhibiting suboptimal responses to ADV plus nucleoside analogue (ADV+NA) therapy for NA-resistant chronic hepatitis B (CHB). Me...
ORIGINAL ARTICLE
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Background/Aims: Hepatic damage during transarterial chemoembolization (TACE) is a critical complication in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Apart from its role in preventing HBV reactivation, there is some evidence for the benefits o...
ORIGINAL ARTICLE
Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
Background/Aims: Radiofrequency ablation (RFA) is one of the most frequently applied curative treatments in patients with a single small hepatocellular carcinoma (HCC). However, the clinical significance of and risk factors for early massive recurrence after RFA—a dreadful even...
ORIGINAL ARTICLE
Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach
Background/Aims: Practice guidelines recommend endoscopic band ligation (EBL) and endoscopic variceal obturation (EVO) for bleeding from esophageal varices and fundal varices, respectively. However, the optimal treatment for bleeding from cardiac varices along the lesser curvatu...
Current Issue
Volume 22(4); Dec 2016
Volume 22(3); September 2016
Volume 22(2); June 2016
Volume 22(1); March 2016
Volume 21(4); December 2015
RSS feed
  • Most-cited are based on citations from 2015 ~ 2017.

    Hepatitis C virus-induced hepatocellular carcinoma
    Nicolas Goossens, Yujin Hoshida
    Clin Mol Hepatol.2015;21(2):105-114.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.105
                                     Cited By 14
    KASL clinical practice guidelines: management of chronic hepatitis B
    Clin Mol Hepatol.2016;22(1):18-75.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.18
                                     Cited By 13
    A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
    Su Jong Yu
    Clin Mol Hepatol.2016;22(1):7-17.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.7
                                     Cited By 12
    Clinical implications of advances in liver regeneration
    Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi
    Clin Mol Hepatol.2015;21(1):7-13.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.7
                                     Cited By 10
    The mutational landscape of hepatocellular carcinoma
    Ju-Seog Lee
    Clin Mol Hepatol.2015;21(3):220-229.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.220
                                     Cited By 9
    Personalized treatment of hepatitis B
    Anna S. Lok
    Clin Mol Hepatol.2015;21(1):1-6.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.1
                                     Cited By 7
    Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
    Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon
    Clin Mol Hepatol.2015;21(2):141-149.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.141
                                     Cited By 7
    Personalized management of cirrhosis by non-invasive tests of liver fibrosis
    Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong
    Clin Mol Hepatol.2015;21(3):200-211.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.200
                                     Cited By 7
    The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
    In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    Clin Mol Hepatol.2015;21(1):32-40.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.32
                                     Cited By 7
    New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
    Hyun Young Woo, Jeong Heo
    Clin Mol Hepatol.2015;21(2):115-121.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.115
                                     Cited By 6
    Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase
    Yasuko Iwakiri
    Clin Mol Hepatol.2015;21(4):319-325.   Published online December 24, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.4.319
                                     Cited By 5
    Imaging findings of mimickers of hepatocellular carcinoma
    Tae Kyoung Kim, Eunchae Lee, Hyun-Jung Jang
    Clin Mol Hepatol.2015;21(4):326-343.   Published online December 24, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.4.326
                                     Cited By 5
    The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
    Goh Eun Chung, Donghee Kim, Min-Sun Kwak, Jong In Yang, Jeong Yoon Yim, Seon Hee Lim, Mustafa Itani
    Clin Mol Hepatol.2016;22(1):146-151.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.146
                                     Cited By 5
    Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
    Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
    Clin Mol Hepatol.2015;21(1):24-31.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.24
                                     Cited By 4
    Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
    Jung Gil Park
    Clin Mol Hepatol.2015;21(3):287-294.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.287
                                     Cited By 4
    Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
    Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong
    Clin Mol Hepatol.2015;21(1):49-59.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.49
                                     Cited By 4
    The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study
    Youn Zoo Cho, So Yeon Park, Eun Hee Choi, Soon Koo Baik, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Moon Young Kim
    Clin Mol Hepatol.2015;21(2):165-174.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.165
                                     Cited By 3
    Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
    Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park
    Clin Mol Hepatol.2015;21(3):279-286.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.279
                                     Cited By 3
    Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
    Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa
    Clin Mol Hepatol.2015;21(1):41-48.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.41
                                     Cited By 3
    Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient
    Jin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahm
    Clin Mol Hepatol.2015;21(1):85-88.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.85
                                     Cited By 3
  • Editorial Office
    The Korean Association for the Study of the Liver
    Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
    TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © The Korean Association for the Study of the Liver. All rights reserved.